Cameron Pye is the CEO and co-founder of Unnatural Products, a biotechnology platform company focused on advancing macrocyclic peptide therapeutics. Cameron earned his undergraduate degree from Whittier College and a PhD in organic chemistry from UC Santa Cruz, where he conducted research in Scott Lokey’s lab. His work there revolved around exploring structure-property relationships of natural and synthetic cyclic peptides, often in collaboration with pharmaceutical companies.

It was in Lokey’s lab that Cameron met his co-founder, Joshua Schwochert, and together they launched Unnatural Products with a mission to make macrocyclic peptide medicinal chemistry scalable and repeatable, leveraging parallel chemistry and machine learning. Under Cameron’s leadership, the company has raised over $35 million in equity financing and secured business development deals with major partners like BridgeBio and Merck, totaling over $850 million in aggregate deal value. Outside of his work, Cameron enjoys trail running, riding motorcycles, and spending time with his partner and dog in the scenic Santa Cruz mountains.